
Overview
Sandeep Bagla is an Interventional Radiologist and President of Prostate Centers USA. He has been practicing for nearly 20 years and his particular area of focus is using embolization to treat Benign Prostatic Hyperplasia, which is also known as Enlarged Prostate. Dr. Bagla uses embolization to slow down blood flow to the prostate, which causes the prostate to shrink. He is board certified in Diagnostic Radiology and Interventional Radiology and licensed to treat patients in Virginia. Dr. Bagla has served as the Principal Investigator of numerous clinical trials and continues to improve novel methods to treat BPH and related conditions.Sandeep Bagla graduated with Honors from St. Georges University School of Medicine in 2002 before completing his residency at Albany Medical Center in NY in Diagnostic Radiology, including being selected as Chief Resident.Dr. Bagla completed subspecialty training in Vascular & Interventional Radiology at George Washington University in 2008 and completed his Certificate of Added Qualification (CAQ) in Vascular & Interventional Radiology.
Dr. Bagla is rated as an Advanced provider by MediFind in Liver Embolization. His top areas of expertise are Enlarged Prostate (BPH), Osteoarthritis, Arthritis, Prostatic Artery Embolization, and Aquablation.
His clinical research consists of co-authoring 54 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Liver Embolization.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- OTHER MANAGED MEDICAID
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2755 Hartland Rd, 110, Falls Church, VA 22043
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Bradford Wood is an Interventional Radiologist in Bethesda, Maryland. Dr. Wood is rated as a Distinguished provider by MediFind in Liver Embolization. His top areas of expertise are Prostate Cancer, Liver Cancer, Enlarged Prostate (BPH), Liver Embolization, and Prostatectomy.
Medstar Medical Group Ii LLC
Nariman Nezami is an Interventional Radiologist and a Radiologist in Washington, Washington, D.c.. Dr. Nezami has been practicing medicine for over 18 years and is rated as an Advanced provider by MediFind in Liver Embolization. His top areas of expertise are Liver Cancer, Mesenteric Venous Thrombosis, Gallbladder Disease, Liver Embolization, and Lithotripsy. Dr. Nezami is currently accepting new patients.
Johns Hopkins Outpatient Center
Dr. Kelvin K. Hong is an Associate Professor and Executive Vice Chair of Radiology within the Johns Hopkins Department of Radiology. A specialist in interventional and vascular radiology, Dr. Hong serves as the Medical Director of the Johns Hopkins Interventional Radiology Center. Dr. Hong earned his medical degree from South Africa’s University Of Witwatersrand Medical School in Parktown. He completed a radiology residency at Parktown West’s College of Medicine/Radiology, as well as a cardiovascular/interventional radiology fellowship and diagnostic radiology residency at The Johns Hopkins Hospital. His areas of clinical expertise include bone, liver and soft-tissue tumors; chronic total occlusions; claudication; deep venous thrombosis; lung, esophageal and kidney cancer; peripheral arterial/vascular disease; renal artery/vascular disease; uterine fibroid tumors; varicocele; and vascular malformations and venous thromboembolism. Dr. Hong performs procedures that include radiofrequency ablation for lung, liver, kidney and bone lesions; transcatheter arterial chemoembolization for liver cancer; lower-extremity angioplasty and stenting; visceral angioplasty and stenting; embolization of uterine fibroid tumors; cryoablation for pain control; and percutaneous laser ablation of varicose veins. Dr. Hong served as editor for the book Percutaneous Tumor Ablation and contributed to Interventional Oncology: Principles and Practice. Dr. Hong is rated as a Distinguished provider by MediFind in Liver Embolization. His top areas of expertise are Fibrolamellar Carcinoma, Bile Duct Obstruction, Neuroendocrine Tumor, Liver Embolization, and Pancreaticoduodenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Enlarged Prostate (BPH)Dr. Bagla isElite. Learn about Enlarged Prostate (BPH).
- Prostatic Artery Embolization
- Advanced
- AquablationDr. Bagla isAdvanced. Learn about Aquablation.
- Liver EmbolizationDr. Bagla isAdvanced. Learn about Liver Embolization.
- OsteoarthritisDr. Bagla isAdvanced. Learn about Osteoarthritis.
- Experienced
- Arteriovenous MalformationDr. Bagla isExperienced. Learn about Arteriovenous Malformation.
- ArthritisDr. Bagla isExperienced. Learn about Arthritis.
- AscitesDr. Bagla isExperienced. Learn about Ascites.
- End-Stage Renal Disease (ESRD)Dr. Bagla isExperienced. Learn about End-Stage Renal Disease (ESRD).
- Lung CancerDr. Bagla isExperienced. Learn about Lung Cancer.
- Peripheral Artery DiseaseDr. Bagla isExperienced. Learn about Peripheral Artery Disease.

